Terumo Corp
TSE:4543
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 129.2177
3 160
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Terumo Corp
Terumo Corp
Cash Equivalents
Terumo Corp
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Terumo Corp
TSE:4543
|
Cash Equivalents
¥194.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
Olympus Corp
TSE:7733
|
Cash Equivalents
¥274.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
19%
|
CAGR 10-Years
1%
|
|
|
Sysmex Corp
TSE:6869
|
Cash Equivalents
¥91.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Cash Equivalents
¥32.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
|
JEOL Ltd
TSE:6951
|
Cash Equivalents
¥39.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
36%
|
CAGR 10-Years
15%
|
|
|
Fukuda Denshi Co Ltd
TSE:6960
|
Cash Equivalents
¥62.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
Terumo Corp
Glance View
Terumo Corporation, founded in 1921 and headquartered in Tokyo, Japan, has carved a significant niche in the global healthcare landscape as a leader in medical technology. With a steadfast commitment to enhancing the quality of life, Terumo focuses on innovative solutions in areas such as blood management, cardiovascular interventions, and surgical devices. Through a history of groundbreaking research and development, Terumo has established a robust portfolio of products that not only meet immediate clinical needs but also pave the way for advancements in patient care. The company’s dedication to sustainability and social responsibility further solidifies its reputation as a trustworthy and forward-thinking organization committed to making a positive impact on society. For investors, Terumo presents an attractive opportunity characterized by steady growth, a diverse global presence, and a solid financial foundation. The company's strategic focus on expanding its international footprint, particularly in emerging markets, positions it to capitalize on the rising demand for healthcare innovations. With an increasingly aging population and a growing emphasis on preventative care and advanced treatments, Terumo's comprehensive array of products is well-placed to address these market dynamics. As it continues to invest in R&D and forge strategic partnerships, Terumo Corporation not only stands as a resilient player in the medical technology sector but also as a company poised for long-term growth and value creation for its shareholders.
See Also
What is Terumo Corp's Cash Equivalents?
Cash Equivalents
194.9B
JPY
Based on the financial report for Sep 30, 2024, Terumo Corp's Cash Equivalents amounts to 194.9B JPY.
What is Terumo Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
6%
Over the last year, the Cash Equivalents growth was 4%. The average annual Cash Equivalents growth rates for Terumo Corp have been -1% over the past three years , 11% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
